Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease.

  • Authors : McPherson ME; Aflac Cancer Center and Blood Disorders Service, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA. ; Hutcherson D

Subjects: Bone Marrow Transplantation*/Bone Marrow Transplantation*/Bone Marrow Transplantation*/adverse effects ; Bone Marrow Transplantation*/Bone Marrow Transplantation*/Bone Marrow Transplantation*/mortality ; Transplantation Conditioning*/Transplantation Conditioning*/Transplantation Conditioning*/adverse effects

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2011 Jan; Vol. 46 (1), pp. 27-33. Date of Electronic Publication: 2010 Mar 22.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Effects of Chemotherapy on Neuroinflammation, Neuronal Damage, Neurogenesis, and Behavioral Performance in Bone Marrow Transplantation Recipient Mice.

  • Authors : Yu ZY; Department of Neurology and Centre for Clinical Neuroscience, Daping Hospital, Third Military Medical University, Chongqing, China.; Institute of Brain and Intelligence, Third Military Medical University, Chongqing, China.

Subjects: Bone Marrow Transplantation* ; Neuroinflammatory Diseases*; Animals

  • Source: Neurotoxicity research [Neurotox Res] 2022 Apr; Vol. 40 (2), pp. 585-595. Date of Electronic Publication: 2022 Apr 05.Publisher: Springer Country of Publication: United States NLM ID: 100929017 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Evaluating pharmacokinetics and pharmacodynamics of intravenous busulfan in pediatric patients receiving bone marrow transplantation.

  • Authors : Kim AH; Department of Pharmaceutical Services, Mattel Children's Hospital at UCLA, Los Angeles, CA 90095, USA.; Tse JC

Subjects: Bone Marrow Transplantation*; Busulfan/Busulfan/Busulfan/*pharmacology ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*pharmacology

  • Source: Pediatric transplantation [Pediatr Transplant] 2009 Dec; Vol. 13 (8), pp. 971-6. Date of Electronic Publication: 2009 Nov 18.Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9802574 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-3046

تفاصيل العنوان

×
Academic Journal

Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome.

Subjects: Bone Marrow Transplantation/Bone Marrow Transplantation/Bone Marrow Transplantation/*methods ; Busulfan/Busulfan/Busulfan/*pharmacokinetics ; Thalassemia/Thalassemia/Thalassemia/*therapy

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2005 Nov; Vol. 36 (10), pp. 839-45.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

تفاصيل العنوان

×
Academic Journal

Accidental busulfan overdose during conditioning for stem cell transplantation.

  • Authors : Jenke A; Universitätsklinik Carl Gustav Carus, Medizinische Klinik I, Fetscherstrasse 74, 01307 Dresden, Germany. ; Freiberg-Richter J

Subjects: Bone Marrow Transplantation/Bone Marrow Transplantation/Bone Marrow Transplantation/*adverse effects ; Busulfan/Busulfan/Busulfan/*poisoning ; Medical Errors/Medical Errors/Medical Errors/*adverse effects

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2005 Jan; Vol. 35 (2), pp. 125-8.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

تفاصيل العنوان

×
Academic Journal

Target dose adjustment of busulfan in pediatric patients undergoing bone marrow transplantation.

  • Authors : Bolinger AM; University of California at San Francisco, Department of Clinical Pharmacy, San Francisco, CA 94143-0622, USA.; Zangwill AB

Subjects: Bone Marrow Transplantation/Bone Marrow Transplantation/Bone Marrow Transplantation/*methods ; Busulfan/Busulfan/Busulfan/*administration & dosage ; Transplantation Conditioning/Transplantation Conditioning/Transplantation Conditioning/*methods

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2001 Dec; Vol. 28 (11), pp. 1013-8.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print Cited Medium: Print ISSN: 0268-3369

تفاصيل العنوان

×
  • 1-10 ل  985 نتائج ل ""busulfan""